EUVIMEDEUVIMED entdecken
Metaanalyse

Net Clinical Benefit of Continuing vs Discontinuing Anticoagulation After Atrial Fibrillation Ablation: Results from a 280,000-Patient Meta-Analysis

Sogol Koolaji, Diana Adrienne Gorog iD, Joshua H Leader, Vias Markides

Thrombosis and Haemostasis · 02.11.2026

DOI: 10.1055/a-2994-8900 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Thrombosis and Haemostasis, erschienen am 02.11.2026. Verfasst von Sogol Koolaji und 3 weiteren Autor:innen. Beteiligte Einrichtung: University of Hertfordshire - College Lane Campus, School of Life and Medical Sciences, England, United Kingdom of Great Britain and Northern Ireland….

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Oral anticoagulation (OAC) in patients with atrial fibrillation (AF) reduces ischaemic stroke (IS), but increases bleeding, including intracranial haemorrhage (ICH). As catheter ablation reduces AF burden and IS risk, we evaluated the net clinical benefit (NCB) of continuing versus discontinuing OAC after AF ablation.

Methods

We conducted a systematic review and meta-analysis of randomized controlled trials (RCTs) and cohort studies comparing OAC continuation versus discontinuation after AF ablation. NCB was calculated as the reduction in IS with continued OAC minus 1.5 × the increase in ICH.

Results

Thirty-eight studies were included (3 RCTs, 35 cohort studies), enrolling 280,415 patients, with 2.7 years’ follow-up. In RCTs, there was no difference between patients on-OAC vs. off-OAC for IS, major bleeding, ICH, or NCB. In cohort studies, IS was similar, but major bleeding (OR, 3.02; 95%CI, 2.06–4.42, p

Autor:innen und Institutionen

  • University of Hertfordshire - College Lane Campus, School of Life and Medical Sciences, England, United Kingdom of Great Britain and Northern Ireland, Hatfield.
  • Imperial College, Cardiology, London, United Kingdom of Great Britain and Northern Ireland, London.
  • E&N Hertfordshire NHS Trust, Cardiology, Hertfordshire, United Kingdom of Great Britain and Northern Ireland.
  • E&N Hertfordshire NHS Trust, Cardiology, Hertfordshire, United Kingdom of Great Britain and Northern Ireland, Hatfield.
  • Royal Brompton & Harefield NHS Foundation Trust, Cardiology, England, United Kingdom of Great Britain and Northern Ireland, London.
  • Imperial College London Faculty of Medicine, NHLI, England, United Kingdom of Great Britain and Northern Ireland, London.

ORCID-Profile: Diana Adrienne Gorog

Zitieren

APA

Koolaji, S., Gorog, D. A., Leader, J. H., & Markides, V. (2026). Net Clinical Benefit of Continuing vs Discontinuing Anticoagulation After Atrial Fibrillation Ablation: Results from a 280,000-Patient Meta-Analysis. Thrombosis and Haemostasis. https://doi.org/10.1055/a-2994-8900

Vancouver

Koolaji S, Gorog DA, Leader JH, Markides V. Net Clinical Benefit of Continuing vs Discontinuing Anticoagulation After Atrial Fibrillation Ablation: Results from a 280,000-Patient Meta-Analysis. Thrombosis and Haemostasis. 2026. doi:10.1055/a-2994-8900

BibTeX
@article{Koolaji2026,
  author = {Koolaji, Sogol and Gorog, Diana Adrienne and Leader, Joshua H and Markides, Vias},
  title = {Net Clinical Benefit of Continuing vs Discontinuing Anticoagulation After Atrial Fibrillation Ablation: Results from a 280,000-Patient Meta-Analysis},
  journal = {Thrombosis and Haemostasis},
  year = {2026},
  doi = {10.1055/a-2994-8900}
}
Kostenlos starten →